Therefore, AS-IV may treat DN by inhibiting interstitial hyperplasia and renal fibrosis through the TGF-β1/Smad/Mir-192 signaling pathway (Mao et al., 2019). The gene discussed is TGFB1; the disease is liver dysplastic nodule.